Gemalto Boosts Cloud Security with a Scalable Virtual Key Management Solution
Gemalto announced a next-generation key management solution, SafeNet Virtual KeySecure, for simpler and stronger cloud security. Companies can extend their data protection policies to private and public clouds and centralize encryption and key management operations across multiple cloud environments.
SafeNet Virtual KeySecure integrates with leading cloud service providers and virtual platforms such as AWS, Microsoft Azure, Google Cloud Platform, IBM Cloud, VMware, Microsoft Hyper-V and OpenStack, to provide companies with a single key management solution spanning multiple private or public cloud environments.
As a result of the ongoing digital transformation within many organizations, data now resides across a growing number of cloud environments and web applications. Security teams are finding it ever more challenging to manage data protection policies, and solutions are often time-consuming and manual. Data protection operations can be simplified by using SafeNet Virtual KeySecure to uniformly view, control, and administer cryptographic policies and keys for sensitive data.
Companies can improve key security and simplify the audit preparation process by retaining ownership and control of encryption keys.
“Businesses need options when it comes to cloud security and shouldn’t be limited to working in just one environment. With SafeNet Virtual KeySecure, organizations are able to move more workloads to the cloud and easily monitor the access and movement of their encrypted data,” said Todd Moore, senior vice president of Encryption Products at Gemalto. “We are seeing a lot of customers who are interested in taking advantage of the business continuity offered by cloud environments, without compromising the security of their most critical asset, data. Current KeySecure customers would also be able to benefit from this new platform and we will be sharing details of a clear migration path with them in the near future.”
SafeNet Virtual KeySecure offers customers:
- Centralized Key Management: Centralized, efficient auditing of key management offers simplified compliance for cloud environments and consolidates key security policies across multiple, disparate encryption systems, protecting current investments
- Flexibility: Customers can easily deploy flexible, high-availability configurations which are built on the latest industry standards, including containers and microservices, across geographically dispersed data centers or cloud service providers.
- Compatibility: Compatibility with the OASIS Key Management Interoperability Protocol (KMIP) standard provides support for a large, growing partner ecosystem, including the SafeNet Data Protection portfolio which provides customers with a broad spectrum of use cases that can be supported. SafeNet Virtual KeySecure also supports key storage in on-premise hardware security modules (HSMs).
According to Sudesh Kumar, Founder and CEO of Kapalya, Californian-based start-up: “As businesses connect to more devices and cloud platforms, they need solutions that offer security without limiting their potential for innovation. With SafeNet Virtual KeySecure, we’re now able to offer the ability to protect data in a seamless and cost-effective way across endpoints, public clouds and private clouds. Businesses should no longer be held back in making full use of the cloud while retaining control of some of their most important assets.”
- Download the SafeNet Virtual KeySecure Product Brief
- Review the findings of the Gemalto and Ponemon: 2018 Global Cloud Data Security Survey
- Read the new IDC Report Analyzing the Business Impact of Encryption
- Watch the SafeNet Virtual KeySecure k170v Product Video
- Learn more about the broader SafeNet Data Protection portfolio
Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.
From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.
Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.
Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.
Tauri Cox, +1 512 257 3916
Sophie Dombres, +33 4 42 36 57 38
Europe Middle East & Africa
Jaslin Huang, +65 6317 3005
Enriqueta Sedano, +52 5521221422
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Veristat Congratulates Agios Pharmaceuticals on the FDA Approval of TIBSOVO®20.8.2018 11:00 | Tiedote
Veristat, a full service Clinical Research Organization (CRO), congratulates Agios on the recent FDA approval of TIBSOVO® (ivosidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA approved test. TIBSOVO®, an oral, targeted inhibitor of the IDH1 enzyme, is the first and only FDA-approved therapy for patients with R/R AML and an IDH1 mutation. Veristat is honored to have supported Agios with the preparation of the New Drug Application (NDA) for ivosidenib. We congratulate Agios on the approval of this ground-breaking therapy for patients with this life-threatening malignancy. Veristat began working with Agios on this compound five years ago, providing statistical and medical writing support for their phase I study for ivosidenib which led to the recent approval. Veristat’s support continued through the preparation of the NDA submission. “Over the last fi
Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies for the 4th Consecutive Year20.8.2018 11:00 | Tiedote
Veristat, a full service Clinical Research Organization (CRO), proudly announces its recognition once again by Inc. Magazine as one of the 5000 fastest-growing private companies in the United States. Since its first appearance on the list in 2015, Veristat has accelerated its growth in size, geographic reach and ability to successfully guide clinical trials through the development process to regulatory approval. “Veristat’s ability to achieve this national recognition and to remain on this list for 4 consecutive years highlights our sustainability, innovation and unfaltering commitment to consistently delivering the highest quality clinical development and regulatory submission services to our clients,” stated Patrick Flanagan, Chief Executive Officer at Veristat. “The meaningful impact that our teams provide to our clients and to lives of the patients their programs benefit is astounding. In 2018, our teams supported five regulatory submissions that were submitted to the US Food & Dru
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)20.8.2018 10:00 | Tiedote
Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCITM trial and GLORIATM-AF Registry Program at the upcoming ESC Congress 2018, organised by the European Society of Cardiology, taking place in Munich, Germany on the 25-29 August 2018. The primary data from these studies have contributed to a positive label update for dabigatran etexilate (Pradaxa®) in the European Union (EU). The primary RE-DUAL PCITM trial investigated anticoagulation in patients with non-valvular atrial fibrillation (AF) following percutaneous coronary intervention (PCI) and stent placement. Data showed significantly lower rates of major or clinically relevant non-major bleeding events for dual therapy with dabigatran etexilate when compared to triple therapy with warfarin without compromise on efficacy.1,2 GLORIATM-AF is a large, prospective, observational study program run in over 40 countries worldwide. The primary analysis of nearly 5000 AF patients treated with dabiga
Alipay Launches World’s First Paperless Tax Refund Service in South Korea20.8.2018 06:24 | Tiedote
Alipay, the world’s leading mobile payment and lifestyle platform operated by Ant Financial Services Group, announced that it has partnered with Global Tax Free (“GTF”), a tax refund agency, to launch the world’s first paperless mobile tax refund function in South Korea. Alipay has consistently been at the forefront of innovation that supports mobile tax refund solutions globally. In early 2017, Alipay initiated a real-time tax refund service in Europe which enabled users to instantly receive tax rebates in their Alipay accounts after scanning their Alipay QR code at airport tax counters. The newly introduced tax refund service in South Korea further simplifies the process by enabling Chinese tourists to apply for and claim tax rebates on their mobile phone app, skipping in-city and airport tax refund counters altogether. After scanning their passports at self-service kiosks prior to leaving South Korea, Chinese tourists can process tax rebates and immediately receive RMB refunds by us
Manchester United Shoots for Success with a “Digital Experience Platform” Powered by HCL16.8.2018 22:02 | Tiedote
Manchester United (NYSE:MANU) has today announced a major milestone on its digital transformation journey with HCL Technologies, with the successful launch of the Manchester United Official app powered by HCL’s digital experience platform. The launch is part of the ongoing digital transformation of the club to provide a real-time, engaging, personalized, and unified experience to Manchester United’s 659 million global followers, which supports the club’s strategy to become a Digital Sports Enterprise. At the heart of this transformation is the digital platform developed by HCL, providing the club with a single view of fans across web and app touchpoints, offering fans a one-stop shop for everything Manchester United. Manchester United’s Group Managing Director Richard Arnold comments: “This app will allow our 659 million Manchester United followers to easily connect to the club they love, wherever they are in the world. Fans will now have the opportunity to follow all Manchester United
4K 4Charity Fun Run Announces Open Registration for IBC201816.8.2018 20:41 | Tiedote
AWS Elemental, an Amazon Web Services (AWS) company, today announced that the fifth annual 4K 4Charity Fun Run at IBC Show will take place at 7:00 a.m. local time on Saturday, Sept. 15 at Amstelpark in Amsterdam. Registration is open at https://4k4charity.com/ibc. Among the non-profits supported by the 4K 4Charity Fun Run at IBC Show is Amsterdam-based StichtingNewTechKids, which provides computer science education for girls, minorities, and economically challenged youth in the Netherlands. The organization supports a computer science teacher training program for primary school teachers with proceeds from 4K 4Charity. Also supported is Iridescent, a global education non-profit that empowers underrepresented young people to become innovators and leaders through engineering and technology. Through their two programs, Curiosity Machine AI Family Challenge and Technovation, Iridescent introduces underserved communities to new technologies and empowers and equips them to apply those technol
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme